In the present study, we assessed BM infiltration with clonal plasma cells as well as BM microenvironment cellular composition by NGF method in patients with BR of MM and compared it to patients with MRDneg status as a “pre-relapse” group and patients with confirmed clinical relapse (RMM group). This evidence concerns the gene NGF and Miyoshi myopathy.